rs267608332

Variant summary

Our verdict is Pathogenic. The variant received 12 ACMG points: 16P and 4B. PVS1PP5_Very_StrongBS2

The NM_001110792.2(MECP2):​c.1196_1202delCCCCACC​(p.Pro399LeufsTer20) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000399 in 552,051 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000061 ( 0 hom., 0 hem., cov: 0)
Exomes 𝑓: 0.000039 ( 0 hom. 4 hem. )

Consequence

MECP2
NM_001110792.2 frameshift

Scores

Not classified

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:4

Conservation

PhyloP100: 3.20

Publications

0 publications found
Variant links:
Genes affected
MECP2 (HGNC:6990): (methyl-CpG binding protein 2) DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. In contrast to other MBD family members, MECP2 is X-linked and subject to X inactivation. MECP2 is dispensible in stem cells, but is essential for embryonic development. MECP2 gene mutations are the cause of most cases of Rett syndrome, a progressive neurologic developmental disorder and one of the most common causes of cognitive disability in females. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2015]
MECP2 Gene-Disease associations (from GenCC):
  • chromosome Xq28 duplication syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • Rett syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, Orphanet, G2P
  • severe neonatal-onset encephalopathy with microcephaly
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • syndromic X-linked intellectual disability Lubs type
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • atypical Rett syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked intellectual disability-psychosis-macroorchidism syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • systemic lupus erythematosus
    Inheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 12 ACMG points.

PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. There are 137 pathogenic variants in the truncated region.
PP5
Variant X-154030661-AGGTGGGG-A is Pathogenic according to our data. Variant chrX-154030661-AGGTGGGG-A is described in ClinVar as Pathogenic. ClinVar VariationId is 143384.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAdExome4 at 21 XL,Unknown,AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001110792.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MECP2
NM_001110792.2
MANE Select
c.1196_1202delCCCCACCp.Pro399LeufsTer20
frameshift
Exon 3 of 3NP_001104262.1A0A140VKC4
MECP2
NM_004992.4
MANE Plus Clinical
c.1160_1166delCCCCACCp.Pro387LeufsTer20
frameshift
Exon 4 of 4NP_004983.1D3YJ43
MECP2
NM_001316337.2
c.881_887delCCCCACCp.Pro294LeufsTer20
frameshift
Exon 5 of 5NP_001303266.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MECP2
ENST00000453960.7
TSL:1 MANE Select
c.1196_1202delCCCCACCp.Pro399LeufsTer20
frameshift
Exon 3 of 3ENSP00000395535.2P51608-2
MECP2
ENST00000303391.11
TSL:1 MANE Plus Clinical
c.1160_1166delCCCCACCp.Pro387LeufsTer20
frameshift
Exon 4 of 4ENSP00000301948.6P51608-1
MECP2
ENST00000630151.3
TSL:5
c.1160_1166delCCCCACCp.Pro387LeufsTer20
frameshift
Exon 4 of 4ENSP00000486089.2P51608-1

Frequencies

GnomAD3 genomes
AF:
0.0000609
AC:
1
AN:
16414
Hom.:
0
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000115
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00000755
AC:
1
AN:
132529
AF XY:
0.0000204
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000155
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000392
AC:
21
AN:
535637
Hom.:
0
AF XY:
0.0000255
AC XY:
4
AN XY:
156659
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
13489
American (AMR)
AF:
0.00
AC:
0
AN:
17484
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
7694
East Asian (EAS)
AF:
0.00
AC:
0
AN:
7836
South Asian (SAS)
AF:
0.00
AC:
0
AN:
22278
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
13189
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
1775
European-Non Finnish (NFE)
AF:
0.0000462
AC:
20
AN:
432938
Other (OTH)
AF:
0.0000528
AC:
1
AN:
18954
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.590
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000609
AC:
1
AN:
16414
Hom.:
0
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
4652
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
3899
American (AMR)
AF:
0.00
AC:
0
AN:
1398
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
448
East Asian (EAS)
AF:
0.00
AC:
0
AN:
763
South Asian (SAS)
AF:
0.00
AC:
0
AN:
374
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
509
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
34
European-Non Finnish (NFE)
AF:
0.000115
AC:
1
AN:
8681
Other (OTH)
AF:
0.00
AC:
0
AN:
209
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.725
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
3
-
-
Rett syndrome (3)
1
-
-
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
3.2
Mutation Taster
=5/195
disease causing (ClinVar)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs267608332; hg19: chrX-153296112; API